Health care and life sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's challenges. The Deloitte network understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life.
A number of factors are prompting global life sciences companies to adopt new business models:
- A changing health care landscape
- Expiring patents and generic competition
- Pricing pressures
- Heightened regulatory scrutiny
- Expansion into emerging markets
- Increasing alliances and acquisitions
- Economic slowdowns are
Our expertise helps you to overcome these influences that prompt global life sciences companies to adopt new business models to counter slowing sales growth and declining profitability, deliver better.